Skip to content
Boca Raton, FL - IMF Patient & Family Seminar 2026 - Saturday Evaluation
1.
I am a (Choose all that apply)
Patient
Care Partner of a Patient
Health Care Provider
Industry Partner
Other (please specify)
2.
Which of the following best applies to you?
This is my first IMF Educational Program
I attend IMF Educational Programs on a regular basis
I have attended IMF Educational Programs previously, but not in the last year
3.
How long ago were you or the person you care for diagnosed? (choose one)
Less than 3 months
Between 3 months and 1 year
Between 1 and 5 years
Between 5 and 10 years
15 or more years
Not applicable
Please only evaluate the presentations that you attended.
4.
Please rate the value of each presentation.
1 - Not Valuable
2 - Slightly Valuable
3 - Moderately Valuable
4 - Very Valuable
5 - Extremely Valuable
President & CEO Address
- Heather Cooper Ortner
1 - Not Valuable
2 - Slightly Valuable
3 - Moderately Valuable
4 - Very Valuable
5 - Extremely Valuable
Fireside Chat: What is the Future of Myeloma with Q & A
- Joseph Mikhael, MD & Carl Ola Landgren, MD
1 - Not Valuable
2 - Slightly Valuable
3 - Moderately Valuable
4 - Very Valuable
5 - Extremely Valuable
Breakout Session for Newly Diagnosed: Frontline Therapy
- Rafat Abonour, MD
1 - Not Valuable
2 - Slightly Valuable
3 - Moderately Valuable
4 - Very Valuable
5 - Extremely Valuable
Breakout Session for Managing Relapsed Myeloma
- Melissa Alsina, MD
1 - Not Valuable
2 - Slightly Valuable
3 - Moderately Valuable
4 - Very Valuable
5 - Extremely Valuable
Find Your Path: Navigating your Myeloma Journey
- Kevin Brigle, PhD, ANP
1 - Not Valuable
2 - Slightly Valuable
3 - Moderately Valuable
4 - Very Valuable
5 - Extremely Valuable
Closing the Gap: Health Disparities in Myeloma
- Joseph Mikhael, MD
1 - Not Valuable
2 - Slightly Valuable
3 - Moderately Valuable
4 - Very Valuable
5 - Extremely Valuable
Breakout Session for Patients Only - Lessons Learned
- Michael Tuohy
1 - Not Valuable
2 - Slightly Valuable
3 - Moderately Valuable
4 - Very Valuable
5 - Extremely Valuable
Breakout Session for Care Partners Only
- Robin Tuohy
1 - Not Valuable
2 - Slightly Valuable
3 - Moderately Valuable
4 - Very Valuable
5 - Extremely Valuable
Controversies in Myeloma
- Joseph Mikhael, MD
1 - Not Valuable
2 - Slightly Valuable
3 - Moderately Valuable
4 - Very Valuable
5 - Extremely Valuable
Ask the Experts with Guest Faculty
1 - Not Valuable
2 - Slightly Valuable
3 - Moderately Valuable
4 - Very Valuable
5 - Extremely Valuable
5.
This presentation increased my understanding of the topic.
1 - Strongly Disagree
2 - Disagree
3 - Neutral
4 - Agree
5 - Strongly Agree
President & CEO Address
- Heather Cooper Ortner
1 - Strongly Disagree
2 - Disagree
3 - Neutral
4 - Agree
5 - Strongly Agree
Fireside Chat: What is the Future of Myeloma with Q & A
- Joseph Mikhael, MD & Carl Ola Landgren, MD
1 - Strongly Disagree
2 - Disagree
3 - Neutral
4 - Agree
5 - Strongly Agree
Breakout Session on Newly Diagnosed: Frontline Therapy
- Rafat Abonour, MD
1 - Strongly Disagree
2 - Disagree
3 - Neutral
4 - Agree
5 - Strongly Agree
Breakout Session on Managing Relapsed Myeloma
- Melissa Alsina, MD
1 - Strongly Disagree
2 - Disagree
3 - Neutral
4 - Agree
5 - Strongly Agree
Find your Path: Navigating your Myeloma Journey
- Kevin Brigle, PhD, ANP
1 - Strongly Disagree
2 - Disagree
3 - Neutral
4 - Agree
5 - Strongly Agree
Closing the Gap: Health Disparities in Myeloma
- Joseph Mikhael, MD
1 - Strongly Disagree
2 - Disagree
3 - Neutral
4 - Agree
5 - Strongly Agree
Breakout Session for Patients Only - Lessons Learned
- Michael Tuohy
1 - Strongly Disagree
2 - Disagree
3 - Neutral
4 - Agree
5 - Strongly Agree
Breakout Session for Care Partners Only
- Robin Tuohy
1 - Strongly Disagree
2 - Disagree
3 - Neutral
4 - Agree
5 - Strongly Agree
Controversies in Myeloma
- Joseph Mikhael, MD
1 - Strongly Disagree
2 - Disagree
3 - Neutral
4 - Agree
5 - Strongly Agree
Ask the Experts with Guest Faculty
1 - Strongly Disagree
2 - Disagree
3 - Neutral
4 - Agree
5 - Strongly Agree
6.
I plan to share what I learned from this program with: (select all that apply)
My healthcare team
My care partner
My family or friends
My support group
On social media
I do not plan to share
Other (please specify)
7.
Please share any additional feedback